Kun Li | Real-world Case Studies | Young Researcher Award

Posted on by ScienceFather

Dr. Kun Li | Real-world Case Studies | Young Researcher Award

Shandong Daizhuang Hospital | China

PUBLICATION PROFILE

Orcid

Scopus

🧑‍⚕️ INTRODUCTION

DR. KUN LI is a renowned clinical medical expert and Associate Professor at Daizhuang Hospital of Shandong Province. With a career built on rigorous academic training and pioneering clinical research, he currently serves as the Director of the Neuroregulation Center. Dr. Li is widely recognized for his contributions in the fields of psychiatry, neuroimaging, and non-invasive brain stimulation. His extensive research and leadership in national scientific projects have positioned him as an influential figure in China’s mental health and neuroscience research community.

🎓 EARLY ACADEMIC PURSUITS

Dr. Kun Li laid a solid academic foundation through his studies at Gannan Medical University, Xinxiang Medical University, and Sichuan University, gaining comprehensive medical and research training. His early academic journey was marked by a deep interest in psychiatric neuroscience, which became the cornerstone of his future research pursuits.

🏥 PROFESSIONAL ENDEAVORS

Professionally, Dr. Li has risen to a prestigious role as Associate Professor and Director of the Neuroregulation Center at Daizhuang Hospital of Shandong Province. In this role, he oversees multiple neuromodulation projects, clinical trials, and interdisciplinary collaborations. His leadership extends to administrative, educational, and research initiatives, making substantial contributions to both clinical practice and scientific innovation.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Li’s research focuses on noninvasive brain stimulation, mental illnesses (notably obsessive-compulsive disorder, depression, and schizophrenia), and brain imaging. His involvement spans several major research projects funded by prominent institutions including the National Natural Science Foundation of China, Henan and Shandong Provincial Departments of Science and Technology, and Peking University Neuroscience Labs. His studies have explored rTMS, chrono-rhythm-based interventions, cerebellar connectomics, and biomarkers for mental health disorders, with a particular emphasis on adolescent mental health and early diagnosis.

🌍 IMPACT AND INFLUENCE

Through his interdisciplinary research, Dr. Li has significantly influenced the landscape of psychiatric treatment in China. His work on neural biomarkers, functional connectivity, and advanced imaging techniques has introduced new diagnostic and therapeutic approaches. As a principal investigator on several high-impact projects, Dr. Li’s research has been instrumental in advancing precision psychiatry and patient-centered care models.

📚 ACADEMIC CITATIONS AND PUBLICATIONS

Dr. Kun Li has authored 21 SCI-indexed journal articles, many as the first or corresponding author. His published work includes studies in Behavioural Brain Research, Neuroscience Letters, Frontiers in Psychiatry, Journal of Affective Disorders, and Schizophrenia Research. His meta-analysis on deep TMS for OCD and reviews on neuromodulation in geriatric depression reflect both breadth and depth in the field. These publications are widely cited and respected in the scientific community.

🏆 HONORS & AWARDS

Dr. Li’s research achievements have earned him the Second Grade Science and Technology Achievement Award from the Education Department of Henan Province (2022). He is also actively recognized through national and provincial funding awards, including youth innovation programs and major science projects. His work has received both peer and institutional recognition for innovation and societal contribution.

🧠 LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Dr. Li continues to lead multiple ongoing research projects (2024–2028) focused on rTMS, light therapy, brain network modeling, and psychosomatic disorders. His ambition to bridge traditional Chinese medicine and modern neuroscience through chrono-rhythm-based exercise interventions highlights a unique interdisciplinary vision. His legacy is being built not only through impactful research but also through mentoring young scientists and contributing to professional medical organizations.

✍️ FINAL NOTE

Dr. Kun Li exemplifies the integration of academic excellence, clinical innovation, and compassionate mental healthcare. With a clear focus on advancing neuroregulation techniques, early intervention in psychiatric disorders, and translational brain research, Dr. Li is a thought leader committed to shaping the future of psychiatry in China and beyond.

📚 TOP NOTES PUBLICATIONS 

Addressing the overlooked challenge of dysphagia in schizophrenia: A call for action

    • Authors: Xiumei Hou, Huimin Gao, Cuiyuan Fu, Kun Li

    • Journal: Asian Journal of Psychiatry

    • Year: 2025

Distributed White Matter Abnormalities in Major Depressive Disorder: A Diffusion Tensor Imaging Combined Support Vector Machine Study

    • Authors: Sen Li, Yinghong Xu, Jian Cui, Kun Li, Shanling Ji, Hailong Shen, Yu Wan, Chunyu Dong, Hao Zheng, Wanru Qiu et al.

    • Journal: Depression and Anxiety

    • Year: 2025

The entorhinal cortex and cognitive impairment in schizophrenia: A comprehensive review

    • Authors: Kun Li, Liju Qian, Chenchen Zhang, Jiajia Zhang, Chuang Xue, Yuebing Zhang, Wei Deng

    • Journal: Progress in Neuro-Psychopharmacology and Biological Psychiatry

    • Year: 2025

Advances in non-invasive neuromodulation techniques for geriatric depression: A comprehensive review

    • Authors: Guanqiao Song, Yihan Wu, Huili Xing, Ronglian Zheng, Yining Kou, Chenchen Zheng, Meng Zhang, Kun Li

    • Journal: Journal of Clinical and Basic Psychosomatics

    • Year: 2025

Deep transcranial magnetic stimulation for treatment-resistant obsessive-compulsive disorder: A meta-analysis of randomized-controlled trials

    • Authors: Kun Li, Liju Qian, Chenchen Zhang, Rui Li, Jinkun Zeng, Chuang Xue, Wei Deng

    • Journal: Journal of Psychiatric Research

    • Year: 2024

weiqi wang | Data collection | Young Scientist Award

Posted on by ScienceFather

Dr. weiqi wang | Data collection | Young Scientist Award

Shandong First Medical University Affiliated Provincial Hospital | China

Publication Profile

Scopus

Dr. Weiqi Wang: Bio Summary 🌟

Dr. Weiqi Wang is a dedicated physician specializing in Neurology at the Shandong First Medical University Affiliated Provincial Hospital in China. With a robust background in neurology, his research focuses on neurovascular unit injury mechanisms following subarachnoid hemorrhage (SAH). He is currently involved in leading and contributing to cutting-edge studies on therapeutic strategies for neurological disorders, particularly in the context of brain-targeted stem cell therapy and neurodegenerative diseases.

🎓 Education

  • PhD in Neurology – Qingdao University, 2018-2021

  • Master’s in Neurology – Shandong First Medical University, 2015-2018

  • Bachelor’s in Clinical Medicine – Jining Medical University, 2010-2015

💼 Professional Experience

  • Physician, Department of Neurology – Shandong First Medical University Affiliated Provincial Hospital (July 2021 – Present)

  • Involved in clinical practice while pursuing various research projects centered on brain injury and neurovascular protection mechanisms.

📑 Academic Citations & Key Publications

  • Wang WeiQi, et al. TAT-mGluR1 Attenuation of Neuronal Apoptosis after Subarachnoid Hemorrhage, ACS Chemical Neuroscience, 2019. (Co-first author)

  • Zhang Cheng, et al. Selective mGluR1 Negative Allosteric Modulator Reduces Blood-Brain Barrier Permeability and Cerebral Edema, Translational Stroke Research, 2020. (Co-first author)

  • Wang HongBin, et al. Negative Allosteric Modulator of mGluR1 Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage, ACS Chemical Neuroscience, 2020. (Co-first author)

  • Zhou XiaoYan, et al. TAT-HSP27 Peptide Improves Neurologic Deficits via Reducing Apoptosis, Frontiers in Cellular Neuroscience, 2022. (Co-first author)

  • Hou YaJun, et al. NT157 Inhibits Glioma Cell Proliferation by Upregulating DR5 Expression, Biomedicine & Pharmacotherapy, 2022. (Other author)

🛠️ Technical Skills

  • Expertise in experimental neurobiology techniques, including stem cell therapies, neurovascular unit research, and gene regulation in neurological disorders.

  • Proficient in animal models, biochemical assays, and molecular biology methods.

📚 Teaching Experience

  • Actively involved in educating medical students and interns in clinical neurology and neurophysiology at Shandong First Medical University, fostering the next generation of healthcare professionals.

🔬 Research Interests

  • Neuroprotection mechanisms in subarachnoid hemorrhage (SAH) and traumatic brain injury.

  • Targeted therapies using stem cell-derived exosomes and signaling pathways, such as mGluR1 and ERK1/2, in treating neurovascular disorders and neurodegenerative diseases.

  • Understanding the molecular and cellular mechanisms behind neuronal apoptosis and recovery after brain injury.

📚 Top Notes Publications 

 TAT-mGluR1 Attenuation of Neuronal Apoptosis through Prevention of MGluR1α Truncation after Experimental Subarachnoid Hemorrhage
  • Authors: Wang WeiQi, Han Ping, Xie RongXia, Yang MingFeng, Zhang Cheng, Mi QiongJie, Sun BaoLiang, Zhang ZongYong
    Journal: ACS Chemical Neuroscience
    Year: 2019
Selective mGluR1 Negative Allosteric Modulator Reduces Blood-Brain Barrier Permeability and Cerebral Edema After Experimental Subarachnoid Hemorrhage
  • Authors: Zhang Cheng, Jiang Ming, Wang WeiQi, Zhao ShiJun, Yin YanXin, Mi QiongJie, Yang MingFeng, Song YuQiang, Sun BaoLiang, Zhang ZongYong
    Journal: Translational Stroke Research
    Year: 2020
 Negative Allosteric Modulator of mGluR1 Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage

  • Authors: Wang HongBin, Wang WeiQi, Wu QingJian, Hou YaJun, Li HanXia, Yang HuiJuan, Yang MingFeng, Sun BaoLiang, Zhang ZongYong
    Journal: ACS Chemical Neuroscience
    Year: 2020

Article: TAT-HSP27 Peptide Improves Neurologic Deficits via Reducing Apoptosis After Experimental Subarachnoid Hemorrhage

  • Authors: Zhou XiaoYan, Sun JingYi, Wang WeiQi, Li ShuXian, Li HanXia, Yang HuiJuan, Yang MingFeng, Yuan Hui, Zhang ZongYong, Sun BaoLiang, Han JinXiang
    Journal: Frontiers in Cellular Neuroscience
    Year: 2022

 NT157 Inhibits Cell Proliferation and Sensitizes Glioma Cells to TRAIL-Induced Apoptosis by Upregulating DR5 Expression

  • Authors: Hou YaJun, Li DaWei, Wang WeiQi, Mao LeiLei, Fu XiaoYan, Sun BaoLiang, Fan CunDong
    Journal: Biomedicine & Pharmacotherapy
    Year: 2022

Zhi-Xin Huang | Neurology | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Zhi-Xin Huang | Neurology | Best Researcher Award

The Affiliated Guangdong Second Provincial General Hospital of Jinan University | China

AUTHOR PROFILE

Scopus

Orcid

EARLY ACADEMIC PURSUITS 🎓

Prof. Dr. Zhi-Xin Huang’s academic journey began with a deep commitment to neurology. His pursuit of higher education started with a Master’s Degree in Neurology from Fujian Medical University (Sep. 2007 – Jul. 2010), followed by a Ph.D. in Neurology from Southern Medical University (Sep. 2011 – Jul. 2014). These foundational years laid the groundwork for his extensive career in the field of cerebrovascular diseases. His educational background provided him with a solid understanding of both theoretical and clinical aspects of neurology, setting the stage for his future research and professional endeavors.

PROFESSIONAL ENDEAVORS 🏥

Prof. Dr. Zhi-Xin Huang has made significant strides in his career since becoming the Chief Physician and Deputy Director of Administration at the Department of Neurology at Guangdong Provincial Second People’s Hospital in 2015. Over the years, he has honed his expertise in complex cerebral angiography and various endovascular treatments, particularly for ischemic cerebrovascular diseases, cerebral aneurysms, arteriovenous fistulas, and malformations. His professional skills extend beyond clinical practices to neuroimaging techniques such as CT, MRI, and DSA, which have been central to his diagnostic and therapeutic work. Additionally, as a Visiting Scholar at the University of Missouri School of Medicine (Dec. 2019 – Feb. 2021), he further enriched his knowledge, focusing on cerebrovascular disease-related studies.

CONTRIBUTIONS AND RESEARCH FOCUS  ON NEUROLOGY🔬

Dr. Huang’s research focus has revolved around cerebrovascular diseases, particularly the mechanisms underlying ischemic cerebrovascular events. His expertise includes not only clinical research design and implementation but also the development of experimental models for validation. His deep proficiency in statistical software like SPSS and R language supports his ability to create and interpret complex research data. In the lab, he is experienced with cell culture, gene transfection, PCR, and Western Blot, and he has developed animal models to investigate neurological diseases. His contributions are widely recognized for their practical impact on the medical community, offering innovative insights into treatment protocols and advancing clinical neurology.

IMPACT AND INFLUENCE 🌍

Prof. Dr. Zhi-Xin Huang’s work has influenced both his local medical community and international spheres. His active roles in prestigious committees, such as the Professional Committee of Interventional Neurology and the Youth Committee of Neuroprotection and Rehabilitation, demonstrate his leadership and influence in advancing medical practices and policies. As a member of the Research Hospital Society of China and the Guangdong Pharmaceutical Enterprise Management Association, he has been instrumental in fostering collaboration and innovation in the field of neurology. Furthermore, his participation in multiple research projects, including the Guangzhou Key R&D Project and Guangzhou Science and Technology Fund, underscores his role in pushing forward cutting-edge research.

ACADEMIC CITATIONS 📚

Dr. Huang’s scholarly work has gained recognition across multiple academic platforms. His published research has been widely cited in various scientific journals and has contributed to the development of new methodologies for treating cerebrovascular diseases. His insights into the use of endovascular therapies and neuroimaging techniques have been pivotal in refining clinical practices. These contributions not only enhance the understanding of complex neurological conditions but also inform ongoing research and clinical guidelines, solidifying his reputation as an influential figure in neurology.

LEGACY AND FUTURE CONTRIBUTIONS 🌱

Prof. Dr. Zhi-Xin Huang’s future contributions to neurology are poised to leave a lasting impact on both the scientific community and clinical practices. With his extensive background in research and clinical experience, he is in an excellent position to continue pioneering new treatment protocols for cerebrovascular diseases. As a dedicated mentor and researcher, Dr. Huang is committed to advancing knowledge and improving patient outcomes, particularly through the use of innovative technologies and personalized treatment strategies. His ongoing involvement in national and international projects suggests a bright future where his legacy as a leader in neurological research will only continue to grow.

RESEARCH PROJECTS AND FUNDING 💰

Throughout his career, Prof. Dr. Zhi-Xin Huang has been the principal investigator for several notable research projects that have attracted significant funding. These include projects supported by the Guangzhou Key R&D Project (500,000 RMB), as well as several completed projects under the Guangzhou Science and Technology Fund (400,000 RMB and 200,000 RMB). His research in the realm of traditional Chinese medicine and medical technology has also been recognized, further emphasizing his dedication to bridging modern and traditional approaches in neurology.

NOTABLE PUBLICATIONS  📑

Effect of INR on Outcomes of Endovascular Treatment for Acute Vertebrobasilar Artery Occlusion
    • Authors: Xu, Y., Huang, Z., Zhang, P., Zhang, M., Sun, W.
    • Journal: Translational Stroke Research
    • Year: 2024
Development and validation of the risk score for estimating suicide attempt in patients with major depressive disorder
    • Authors: Huang, Z.-X., Wang, Q., Lei, S., Zhang, C., Zhang, X.
    • Journal: Social Psychiatry and Psychiatric Epidemiology
    • Year: 2024
Quaternion Cross-Modality Spatial Learning for Multi-Modal Medical Image Segmentation
    • Authors: Chen, J., Huang, G., Yuan, X., Zhu, J., Huang, Z.
    • Journal: IEEE Journal of Biomedical and Health Informatics
    • Year: 2024
QMLS: quaternion mutual learning strategy for multi-modal brain tumor segmentation
    • Authors: Deng, Z., Huang, G., Yuan, X., Huang, Z., Liang, Z.
    • Journal: Physics in Medicine and Biology
    • Year: 2024
Endovascular treatment effect in vertebrobasilar artery occlusion patients with posterior circulation Acute Stroke Prognosis Early CT Score (pc-ASPECTS) <6
    • Authors: Zhang, P., Huang, Z., Xu, Y., Luo, G., Sun, W.
    • Journal: Journal of NeuroInterventional Surgery
    • Year: 2024

Go Inokuchi | Neurology | Best Researcher Award

Posted on by ScienceFather

Dr. Go Inokuchi | Neurology | Best Researcher Award

Doctorate at Kakogawa Central City Hospital, Japan

 Profiles

 Orcid Profile

📐📚  Academic Background

Dr. Go Inokuchi, M.D., Ph.D., is a distinguished otolaryngologist specializing in head and neck surgery, currently serving as the Director of The Clinical Trial and Research Center at Kakogawa Central City Hospital. With a career spanning over two decades, Dr. Inokuchi has made significant contributions to both clinical practice and research. His expertise in otology and rhinology is complemented by his academic role as a Visiting Professor at Kobe University Graduate School of Medicine. Dr. Inokuchi is recognized for his innovative research in inner ear mechanisms and head and neck oncology, reflected in numerous publications and prestigious grants from the Japan Society for the Promotion of Science.

🎓Education 

Dr. Inokuchi completed his M.D. in 2003 and his Ph.D. in 2010, both from Kobe University School of Medicine. His rigorous academic training laid the foundation for a successful career in medicine and research, where he has continually sought to bridge the gap between clinical practice and scientific inquiry.

🏥 Professional Experience

Dr. Inokuchi’s professional journey began as a Junior Resident in Otolaryngology at Kobe University Hospital. He advanced through various positions, including Senior Resident, Clinical Fellow in Otology, and Assistant Chief Doctor at the Nishi-Kobe Medical Center. In 2017, he became an Associate Professor at Kobe University Graduate School of Medicine, where he contributed significantly to the Department of Otolaryngology – Head and Neck Surgery. Since 2023, Dr. Inokuchi has led the Clinical Trial and Research Center, enhancing patient care and pioneering clinical research initiatives.

🔬 Research Interests

Dr. Inokuchi’s research focuses on inner ear mechanisms, cochlear efferent systems, and head and neck oncology. His work on acoustic trauma models and the development of cochlear systems using mutated mouse models has garnered significant attention. He has conducted clinical research on congenital cholesteatoma and explored the role of myeloid-derived suppressor cells in cancer metabolism. His research has been published in prestigious journals, showcasing his dedication to advancing medical knowledge and improving patient outcomes.

📖 Publication Top Noted

Olfactory and Taste Dysfunctions Caused by COVID-19: A Nationwide Study

Authors: Miwa, T., Mori, E., Sekine, R., Kimura, Y., Kobayashi, M., Shiga, H., Tsuzuki, K., Suzuki, M., Kondo, K., Suzaki, I., et al.

Journal: Rhinology

Year: 2023

Expressions of NeuroD and GAP43 as Diagnostic Markers for Olfactory Neuroblastoma

Authors: Tatsuya Furukawa, Shun Tatehara, Masanori Teshima, Hirotaka Shinomiya, Go Inokuchi, Masato Komatsu, Shigeo Hara, Yoh Zen, Ken-ichi Nibu

Journal: Auris Nasus Larynx

Year: 2023

Surgical Treatment of Bony Nasal Airway Stenosis in a Patient with Adult Crouzon’s Syndrome

Authors: Tatsuhiko Kamikonya, Go Inokuchi, Shun Tatehara, Mitsuko Yui, Ken-ichi Nibu

Journal: Journal of Surgical Case Reports

Year: 2022

Validation of Epistaxis Severity Score for Hereditary Hemorrhagic Telangiectasia in Japan

Authors: Masaki Hayama, Yohei Maeda, Takashi Shikina, Shun Tatehara, Go Inokuchi, Jeffrey B Hoag, Tomoharu Sato, Sho Obata, Ayaka Nakatani, Yuta Amano, et al.

Journal: Auris Nasus Larynx

Year: 2022

Frontal Sinusitis Associated with Orbital Decompression for Graves’ Orbitopathy

Authors: Tatehara, S., Inokuchi, G., Takeda, H., Kuroki, S., Fujio, H., Azumi, A., Nibu, K.I.

Journal: Auris Nasus Larynx

Year: 2020

Characteristics of Smell Identification Test in Patients with Parkinson Disease

Authors: Fujio, H., Inokuchi, G., Tatehara, S., Kuroki, S., Fukuda, Y., Kowa, H., Nibu, K.-I.

Journal: Clinical and Experimental Otorhinolaryngology

Year: 2019